Cero Therapeutics Holdings, Inc. (Ticker: CERO) Officer YK Bioventures Opportunities GP I, LLC sold 3,250,000 shares of common stock on October 10, 2024, at an average price of approximately $0.10 per share. Following this transaction, their indirect ownership stands at 22,620,783 shares. This sell-off by a senior officer may indicate a cautious outlook on the company's short-term prospects, and investors should consider this along with other market information before making investment decisions.